000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥ 23.42
arrow_downward
-1.64%(-0.39) 1D
10-р сарын 16, 15:04:48 (GMT+8) · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CN¥ 24.04
High
CN¥ 24.76
Low
CN¥ 23.09
Mkt. cap
27.13 тэрбум
Avg. vol.
16.27 сая
Volume
15.09 сая
Dividend
1.61%
Quarterly dividend
CN¥ 0.09
Ex-dividend date
2026 оны 10-р сарын 8
P/E ratio
31.78
52-wk high
CN¥ 28.50
52-wk low
CN¥ 14.89
EPS
CN¥ 0.74
Shares outstanding
1.16 тэрбум
No. of employees
7 мян
Open
CN¥ 24.04
High
CN¥ 24.76
Low
CN¥ 23.09
Mkt. cap
27.13 тэрбум
Avg. vol.
16.27 сая
Volume
15.09 сая
Dividend
1.61%
Quarterly dividend
CN¥ 0.09
Ex-dividend date
2026 оны 10-р сарын 8
P/E ratio
31.78
52-wk high
CN¥ 28.50
52-wk low
CN¥ 14.89
EPS
CN¥ 0.74
Shares outstanding
1.16 тэрбум
No. of employees
7 мян
News stories
From web sources and news partners
Simply Wall Street
·
16 минутын өмнө
Microsoft (MSFT) Secures 1,100 MW Indiana Power Deal
Yahoo Finance
·
29 минутын өмнө
3 Reasons the Vanguard S&P 500 ETF Could Be Worth Holding for the Next 20 Years
ad-hoc-news.de
·
8 минутын өмнө
Shentel schedules October 28 results for Shenandoah Telecommunications stock
MarketWatch
·
23 цагийн өмнө
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd